Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...

NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related ...

Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...

Numerous autoimmune diseases are associated with the development of age-related macular degeneration (AMD), according to research presented at the 2025 Association for Research and Vision in ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

NIH Scientists Test in an Animal Model a Surgical Technique to Improve Cell Therapy for Dry Age-Related Macular Degeneration ...

An East Tennessee State University researcher will use a $2.6 million grant from the National Institutes of Health to study ...

The Business Research Company’s Juvenile Macular Degeneration Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 27, 2025 ...

Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...

Inmed Pharmaceuticals Inc. has divulged cannabinoid CB1 and/or CB2 receptor modulators reported to be useful for the treatment of neurodegeneration and age-related macular degeneration.